<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="60363">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01869335</url>
  </required_header>
  <id_info>
    <org_study_id>15/13</org_study_id>
    <nct_id>NCT01869335</nct_id>
  </id_info>
  <brief_title>A Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens</brief_title>
  <official_title>A Randomized Study Comparing ex Vivo MRI Versus Radiography of Breast Specimens in Evaluating Tumor-free Margins After Surgical Resection of Breast Microcalcifications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</source>
  <oversight_info>
    <authority>Italy: National Institute of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Radiography of breast specimens is currently the only radiological procedure used to verify
      removal of microcalcifications and presence of tumor-free margins after breast surgical
      resection. Ex vivo MRI will be tested for its ability to detect residual tumor tissue not
      detected by radiography in resected breast tumor specimens and/or its ability to verify
      tumor-free margins in breast cancer detected by MRI only.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">May 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Diagnostic efficacy of Magnetic Resonance Imaging (MRI) versus radiography in evaluating tumor-free margins in breast cancer specimens</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diagnostic efficacy will be evaluated by statistical analysis</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>radiography</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm1: patients undergo mammographic localizations and radiography of the specimen after surgical resection.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRI (magnetic resonance imaging)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Arm2: patients undergo MRI localization and ex vivo MRI after surgical resection.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>radiography</intervention_name>
    <arm_group_label>radiography</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI (magnetic resonance imaging)</intervention_name>
    <arm_group_label>MRI (magnetic resonance imaging)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women with malignant breast disease identified by microcalcifications without
             clinically evident disease

          -  Women candidate to breast preserving surgery

        Exclusion Criteria:

          -  Cardiac pacemaker, defibrillators, cardiac monitors

          -  Brain stimulators, implantable spinal stimulators

          -  Vascular and aneurismal clips

          -  Hemostatic clips

          -  Infusion pumps

          -  Glaucoma drainage implants

          -  Metallic foreign body positioned in vital organ of the patients

          -  Some heart valves

          -  Some vascular access ports, infusion pumps and catheters

          -  Permanent contraceptive tubal device

          -  Kidney disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Roberto Agresti, MD</last_name>
    <phone>+39 02 2390</phone>
    <phone_ext>2168</phone_ext>
    <email>roberto.agresti@istitutotumori.mi.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Nazionale dei Tumori</name>
      <address>
        <city>Milan</city>
        <zip>20133</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Roberto Agresti, MD</last_name>
      <phone>+39 022390</phone>
      <phone_ext>2168</phone_ext>
      <email>roberto.agresti@istitutotumori.mi.it</email>
    </contact>
    <investigator>
      <last_name>Roberto Agresti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Elshof LE, Rutgers EJ, Deurloo EE, Loo CE, Wesseling J, Pengel KE, Gilhuijs KG. A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results. Breast Cancer Res Treat. 2010 Dec;124(3):707-15. doi: 10.1007/s10549-010-1064-z. Epub 2010 Jul 22.</citation>
    <PMID>20652399</PMID>
  </reference>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>June 4, 2013</lastchanged_date>
  <firstreceived_date>May 24, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fondazione IRCCS Istituto Nazionale dei Tumori, Milano</investigator_affiliation>
    <investigator_full_name>Roberto Agresti, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>breast cancer</keyword>
  <keyword>MRI</keyword>
  <keyword>mammography</keyword>
  <keyword>microcalcifications</keyword>
  <keyword>Local staging of breast microcalcifications</keyword>
  <keyword>Evaluation of ex vivo MRI for breast malignancies detected by MRI only</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
